Empagliflozin and linagliptin

Generic name: Empagliflozin And Linagliptin
Brand names: Glyxambi
Dosage form: oral tablet (10 mg-5 mg; 25 mg-5 mg)
Drug class: Antidiabetic combinations

Usage of Empagliflozin and linagliptin

Empagliflozin and linagliptin is a combination medicine used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.

Empagliflozin and linagliptin is also used to lower the risk of death from heart attack, stroke, or heart failure in adults with type 2 diabetes who also have heart disease.

empagliflozin and linagliptin is not for treating type 1 diabetes.

Empagliflozin and linagliptin may also be used for purposes not listed in this medication guide.

Empagliflozin and linagliptin side effects

Get emergency medical help if you have signs of an allergic reaction: hives, itching, flaking or peeling skin; trouble swallowing, difficult breathing; swelling of your face, lips, tongue, or throat.

Seek medical attention right away if you have signs of a serious genital infection (penis or vagina): burning, itching, odor, discharge, pain, tenderness, redness or swelling of the genital or rectal area, fever, not feeling well. These symptoms may get worse quickly.

Empagliflozin and linagliptin may cause serious side effects. Call your doctor at once if you have:

pain and burning when you urinate, painful urination;

a light-headed feeling, like you might pass out;

low blood sugar--headache, hunger, sweating, irritability, dizziness, fast heart rate, and feeling anxious or shaky;

heart problems--swelling, rapid weight gain, feeling short of breath; or

dehydration--dizziness, confusion, feeling very thirsty, less urination.

Stop taking this medicine and call your doctor at once if you have:

severe or ongoing pain in your joints;

serious skin reaction--itching, blisters, breakdown of the outer layer of skin;

ketoacidosis (too much acid in the blood)--nausea, vomiting, stomach pain, confusion, unusual drowsiness, or trouble breathing; or

pancreatitis--severe pain in your upper stomach spreading to your back, nausea and vomiting.

Common side effects of empagliflozin and linagliptin may include:

a bladder infection; or

cold symptoms such as runny or stuffy nose, sneezing, sore throat.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Empagliflozin and linagliptin

You should not use this medicine if you are allergic to empagliflozin or linagliptin, or if you have:

severe kidney disease (or if you are on dialysis);

a history of severe allergic or skin reaction after taking empagliflozin or linagliptin; or

diabetic ketoacidosis (call your doctor for treatment).

Tell your doctor if you have ever had:

liver or kidney disease;

a bladder infection or urination problems;

a pancreas disorder;

heart failure;

gallstones;

a genital infection (penis or vagina);

alcoholism, or if you currently drink large amounts of alcohol;

if you are on a low salt diet;

if you are 65 or older;

if you have a planned surgery; or

high cholesterol or triglycerides.

Follow your doctor's instructions about using this medicine if you are pregnant or you become pregnant. Controlling diabetes is very important during pregnancy.

You should not use empagliflozin and linagliptin during the second or third trimester of pregnancy.

Do not breastfeed.

Relate drugs

How to use Empagliflozin and linagliptin

Usual Adult Dose for Diabetes Type 2:

Initial dose: Empagliflozin 10 mg-linagliptin 5 mg orally once a day in the morning-For patients tolerating therapy, may increase to empagliflozin 25 mg-linagliptin 5 mg once a day Maximum dose: Empagliflozin 25 mg-linagliptin 5 mg per dayComments: -Not recommended in patients with type 1 diabetes mellitus as it may increase the risk of diabetic ketoacidosis in these patients. -Has not been studied in patients with a history of pancreatitis and it is not know whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis during therapy. -When used in combination with insulin or insulin secretagogues, a lower dose of the insulin secretagogues or insulin may be necessary to reduce the risk of hypoglycemia.Uses: -As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.-Empagliflozin is indicated to reduce the risk of cardiovascular death in patients with diabetes mellitus and established cardiovascular disease.

Warnings

Stop taking empagliflozin and linagliptin and call your doctor at once if you have signs of a serious side effect, such as severe stomach pain (may spread to your back), vomiting, tiredness, or trouble breathing.

Tell your doctor if you are sick with vomiting or diarrhea, or if you eat or drink less than usual.

This medicine can cause serious infections around the penis or vagina. Get medical help right away if you have burning, itching, odor, discharge, pain, tenderness, redness or swelling of the genital or rectal area, fever, or if you don't feel well.

What other drugs will affect Empagliflozin and linagliptin

Other drugs may increase or decrease the effects of empagliflozin and linagliptin on lowering your blood sugar. Tell your doctor about all your current medicines and any you start or stop using, especially:

insulin, or other oral diabetes medicine;

rifampin (to treat tuberculosis); or

a diuretic or "water pill."

This list is not complete. Other drugs may affect empagliflozin and linagliptin, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed in this medication guide.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.